Ryan Alexander Jones

Chief Financial Officer, Kyverna Therapeutics, Inc.

Companies

Kyverna Therapeutics, Inc.Chief financial officer Feb 7, 2024 to Jul 1, 2025¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kyverna Therapeutics, Inc. KYTX55,950 shares²$334.0K at $5.97Apr 11, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 11, 2025Granted 12,000 shares of Kyverna Therapeutics, Inc.²
May 28, 2024Exercised options 7,146 shares at $0.73 of Kyverna Therapeutics, Inc.³
May 28, 2024Exercised options 10,870 shares at $0.73 of Kyverna Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKyverna Therapeutics, Inc., Chief financial officer
2
SEC EDGARKyverna Therapeutics, Inc. shares after the filing of Apr 11, 2025
3
SEC EDGARForm 4 filed May 29, 2024